Ocular Therapeutix, Inc. (OCUL)
NASDAQ·Healthcare·Biotechnology
$9.32
-2.21%
Mkt Cap $2.03B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (12 analysts)
$27.00
Range $21.00 – $31.00
Implied Upside
+189.9%
Consensus $27.00 vs current $9.32
NASDAQ·Healthcare·Biotechnology
$9.32
-2.21%
Mkt Cap $2.03B
Buy
9
Hold
0
Sell
0
Price Target (12 analysts)
$27.00
Range $21.00 – $31.00
+189.9%
Consensus $27.00 vs current $9.32